UNSPSC 51273914: Benzocaine/cetylpyridinium chloride/terpin hydrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class NT300. This VA Drug Class (NT300) classifies this compound as belonging to the group ANESTHETICS, MUCOSAL.

UNSPSC 51273914 Benzocaine/cetylpyridinium chloride/terpin hydrate is a Commodity code that encompasses over-the-counter and pharmaceutical throat lozenges and topical anesthetics used in public health, emergency response, and pharmacy benefit programs. State and local governments procure these products through county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The products appear in procurement activity ranging from community health initiatives and emergency preparedness to multi-state generic pharmaceutical distribution programs, where they are bundled with broader OTC and generic pharmaceutical catalogs.

Recent solicitation activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking naloxone and drug deactivation systems with quarterly deliveries to its Community Health Building, with responses due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would bypass traditional pharmacy benefit managers and wholesalers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and awarded vendors to supply through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC beginning July 1, 2026.